NEW YORK, June 4, 2026, 10:02 EDT
UnitedHealth Group shares climbed over 5% Thursday morning after Bank of America upgraded the stock to Buy and Morgan Stanley raised its price target. Wall Street is showing new support for the health insurer’s recovery bet.
Investors are weighing if UnitedHealth’s first-quarter bounce really means medical costs are settling down, or if it was just a blip from lighter flu season and bad weather. Managed-care stocks have traded on medical-cost “utilization”—how often people go to the doctor—after a run of bigger claims. BofA’s Kevin Fischbeck said new data “make it more difficult to believe” Q1 was all about flu and storms, according to TipRanks. TipRanks
BofA boosted its price target on UnitedHealth to $450, up from $420, and upgraded the stock to Buy from Neutral. Seeking Alpha reported the shares were on track to open higher after dropping five days in a row, after BofA called out what it sees as a favorable setup for second-quarter earnings.
Morgan Stanley’s Erin Wright lifted her price target to $453 from $395 and kept an Overweight call. Wright said managed-care stocks have been “grinding higher” with signs of softer utilization and pointed to possible artificial-intelligence savings for managed-care companies across both revenue and costs. TipRanks
UnitedHealth was up 5.7% to around $398 as of 10 a.m. in New York, MarketScreener data showed. Shares have climbed about 21% so far this year. The average target from 28 analysts is around $404, tighter to the current level than the new calls from BofA and Morgan Stanley.
Peers got a lift, too. Elevance Health, Cigna, and Humana were all up early Thursday. Investors seemed to read UnitedHealth’s calls as a sector indicator, not just a move on the single name.
UnitedHealth is still pitching itself as a turnaround, not a pure growth play. The first quarter numbers were $111.7 billion in revenue, a 2% rise, with adjusted EPS at $7.23. In April, UnitedHealth bumped its 2026 adjusted earnings target to over $18.25 a share. CEO Stephen Hemsley at the time said the company was focused on affordability, transparency and making care more connected.
UnitedHealth’s board approved a $2.32 quarterly dividend for shareholders of record on June 15, with payment set for June 23. That’s higher than the $2.21 paid in the first quarter, according to the company’s dividend history page.
More bullish price targets are coming in. In a May 27 writeup on “safe” long-term stocks, Insider Monkey noted Bernstein boosted its target on UnitedHealth to $492 from $444 and Barclays went to $429 from $373, with both sticking to their positive ratings. UnitedHealth also showed up with 130 hedge fund holders, according to the piece. Insider Monkey
Downside risk still sticks around. Massachusetts filed suit against UnitedHealth’s insurance arm on May 29, saying it defrauded the state Medicaid system out of over $100 million by “upcoding,” a billing tactic to make diagnoses look more serious and boost payments. UnitedHealth said the suit is “meritless.” Reuters
Right now, traders are watching claims trends more than the legal risk. That could change fast. If medical use trends climb in June or July, or if regulators and state AGs move in, those new price targets might turn out to be less of a floor and more of another hurdle for a company still working to rebuild trust.
Related articles: NYSE:UNH
